Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
78.73
+15.20 (23.92%)
Jul 28, 2026, 11:57 AM EDT - Market open
Kiniksa Pharmaceuticals International, Employees
Kiniksa Pharmaceuticals International, had 366 employees as of December 31, 2025. The number of employees increased by 51 or 16.19% compared to the previous year.
Employees
366
Change (1Y)
51
Growth (1Y)
16.19%
Revenue / Employee
$2,297,399
Profits / Employee
$220,377
Market Cap
6.06B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 366 | 51 | 16.19% | 366 | 0 |
| Dec 31, 2024 | 315 | 18 | 6.06% | 315 | 0 |
| Dec 31, 2023 | 297 | 77 | 35.00% | 297 | 0 |
| Dec 31, 2022 | 220 | 5 | 2.33% | 220 | 0 |
| Dec 31, 2021 | 215 | 47 | 27.98% | 215 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 890 |
| Indivior Pharmaceuticals | 838 |
| Supernus Pharmaceuticals | 778 |
KNSA News
- 1 hour ago - Kiniksa rises 22.7% - TheFly
- 3 hours ago - Kiniksa Pharmaceuticals International, Earnings Call Transcript: Q2 2026 - Transcripts
- 3 hours ago - Kiniksa Pharmaceuticals International, Earnings release: Q2 2026 - Filings
- 3 hours ago - Kiniksa Pharmaceuticals International, Slides: Q2 2026 - Filings
- 4 hours ago - Kiniksa reports Q2 EPS 30c, consensus 28c - TheFly
- 4 hours ago - Kiniksa raises FY26 revenue view to $980M-$995M from $930M-$945M - TheFly
- 4 hours ago - Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 4 days ago - Kiniksa Pharmaceuticals to Report Second Quarter 2026 Financial Results on July 28, 2026 - GlobeNewsWire